CA Patent

CA2626134C — Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders

Assigned to Sprout Pharmaceuticals Inc · Expires 2013-12-24 · 12y expired

What this patent protects

The invention relates to the use of benzimidazolone derivatives of formula (I) for the preparation of a medicament for the treatment of premenstrual and other female sexual disorders.

USPTO Abstract

The invention relates to the use of benzimidazolone derivatives of formula (I) for the preparation of a medicament for the treatment of premenstrual and other female sexual disorders.

Drugs covered by this patent

Patent Metadata

Patent number
CA2626134C
Jurisdiction
CA
Classification
—
Expires
2013-12-24
Drug substance claim
No
Drug product claim
No
Assignee
Sprout Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.